# Lifebanc – FDA Inspection, Nov 2, 2010

Source: https://www.keypedia.com/records/fda_inspections/lifebanc/ab9bf3da-7d75-49f8-8e44-e58150d0459e
Source feed: FDA_Inspections

> FDA inspection 696611 of Lifebanc, November 02, 2010. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 1271. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 696611
- Company Name: Lifebanc
- Inspection Date: 2010-11-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1314576 - 2026-04-21
- FDA Inspection 1191143 - 2022-11-07
- FDA Inspection 1111717 - 2019-11-22
- FDA Inspection 1022398 - 2017-08-11
- FDA Inspection 930447 - 2015-06-18

Company: https://www.keypedia.com/companies/lifebanc/b527a94f-5087-4dea-8a2d-e6b69fadd8f5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d